Rubnitz JE - Search Results

1

Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.

Sandlund JT, Harrison PL, Rivera G, Behm FG, Head D, Boyett J, Rubnitz JE, Gajjar A, Raimondi S, Ribeiro R, Hudson M, Relling M, Evans W, Pui CH. Sandlund JT, et al. Among authors: rubnitz je. Blood. 2002 Jul 1;100(1):43-7. doi: 10.1182/blood.v100.1.43. Blood. 2002. PMID: 12070006 Free article.

2

Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML. Rubnitz JE, et al. Blood. 1994 Jul 15;84(2):570-3. Blood. 1994. PMID: 8025282 Free article.

3

11q23 rearrangements in acute leukemia.

Rubnitz JE, Behm FG, Downing JR. Rubnitz JE, et al. Leukemia. 1996 Jan;10(1):74-82. Leukemia. 1996. PMID: 8558942 Review.

4

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR. Shurtleff SA, et al. Among authors: rubnitz je. Leukemia. 1995 Dec;9(12):1985-9. Leukemia. 1995. PMID: 8609706

5

Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.

Rubnitz JE, Behm FG, Curcio-Brint AM, Pinheiro RP, Carroll AJ, Raimondi SC, Shurtleff SA, Downing JR. Rubnitz JE, et al. Blood. 1996 Jun 1;87(11):4804-8. Blood. 1996. PMID: 8639852 Free article.

6

High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.

Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, Pui CH, Shih LY. Liang DC, et al. Among authors: rubnitz je. Leukemia. 1996 Jun;10(6):991-3. Leukemia. 1996. PMID: 8667657

7

Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.

Shih LY, Chou TB, Liang DC, Tzeng YS, Rubnitz JE, Downing JR, Pui CH. Shih LY, et al. Among authors: rubnitz je. Leukemia. 1996 Sep;10(9):1456-8. Leukemia. 1996. PMID: 8751462

8

Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.

Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG. Rubnitz JE, et al. Blood. 1997 Feb 15;89(4):1143-6. Blood. 1997. PMID: 9028935 Free article. Clinical Trial.

9

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.

Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG. Rubnitz JE, et al. J Clin Oncol. 1997 Mar;15(3):1150-7. doi: 10.1200/JCO.1997.15.3.1150. J Clin Oncol. 1997. PMID: 9060558

10

Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia.

Rubnitz JE, Pui CH. Rubnitz JE, et al. Curr Opin Hematol. 1997 Jul;4(4):233-41. doi: 10.1097/00062752-199704040-00003. Curr Opin Hematol. 1997. PMID: 9260050 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters